drugset / Trial / NCT02154646
A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to evaluate the safety and side effects of LY2157299 in combination with gemcitabine in Japanese participants with pancreatic cancer that is advanced or has spread to another part of the body.
Timeline
- Start
- 2014-05
- Primary completion
- 2014-09
- Completion
- 2015-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Galunisertib | Small molecule | 150 mg | Oral |
| Background | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |